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Abstract
Background: Tuberculosis is a major public health problem
throughout the world particularly in resource limited countries.
Measuring and reporting of TB treatment outcomes and identify-
ing associated factors are fundamental part of TB treatment. The
aim of this study was to assess TB treatment outcome and associ-
ated factors among TB patients in Wolayta Sodo Teaching and
Referral Hospital, Southern Ethiopia.
Design and Method: Facility based retrospective cohort study
was conducted in Wolayta Sodo Teaching and Referral Hospital.
All TB patients who registered during September 2014 to August
2019 and had known treatment outcome were included in the
study. The data were collected using pretested structured data
extraction format that included demographic, clinical and treat-
ment outcome variables. SPSS Version 23 for windows was used
for data processing. Bivariate and multivariate analysis with 95%
confidence interval (CI) was employed to infer associations
between the independent and dependent variables.
Results: Of total 232 TB patients included in the study, 54.3%
were male, 80.2% were urban residents, 65.9% were pulmonary
TB (PTB). From the total 153 PTB cases, 31.5% were smear pos-
itive, 17.2% were HIV co-infected and all of them were on
antiretroviral treatment. Most, 97.0% of the TB cases were newly
diagnosed and all were treated as first line treatment category. The
overall treatment success rate was 82.5% (28% cured 54.3% com-
pleted), 11.2% loss to follow-up, 4.7% dead and 0.9% treatment
failure. The treatment success rate of HIV co-infected TB patients
was 77.5%. There was no significant association between TB
treatment outcome and age, sex, residence, type of TB, category
of patients and HIV status.
Conclusion: The treatment success rate was low (82.5%)
which is below the 90% threshold defined standard with high pro-
portion of patient’s lost to follow-up (11.2%). A higher number of
transfer-out cases were recorded in this study. Thus, supervision
and monitoring of DOTs implementation, improved counseling
service, mechanisms for lost to follow-up patients should be
strengthen. Establish efficient referral and contact tracing mecha-
nisms for transferred-out cases and document their treatment out-
comes of status is also fundamental.
Introduction
Tuberculosis (TB) remains a major public health problem
throughout the world.1 TB is the ninth leading cause of death
worldwide and the leading cause from a single infectious agent.2
There were an estimated 1.2 million TB deaths among HIV-nega-
tive people in 2018 and an additional 251 000 deaths among HIV-
positive people. In 2018 an estimated 10.0 million people fell ill
with TB globally, a number that has been relatively stable in recent
years. The burden of disease extremely varies among different
countries, from fewer than five to more than 500 new cases per
100 000 population per year.3
A resent systematic review and meta-analysis on TB which
involves 34 studies conducted in Ethiopia revealed that the pooled
estimate of successful TB treatment was 83.7%. Of successfully
treated cases, 33.9% were cured and the remaining completed
cases.4 This finding is nearly similar with WHO report which
showed treatment success rates of 85% for TB.3 A 5-year retro-
spective study conducted at Addis Ababa on childhood TB and
treatment outcome stated that 85.5% participants were successful-
ly treated while rates of mortality and defaulting from treatment
were 3.3% and 3.8%, respectively.5
In Ethiopia, recognition and amendment of treatment outcome
is not feasible with poor surveillance system as well as limited
monitoring and evaluation of the health system. Accurate record-
ing and reporting of TB treatment outcomes and associated factors
is fundamental to facilitate the End TB Strategy set target TB
treatment success rate 90% by 2025.2 Identifying and measure this
information is important for health professionals, programmers
and policymakers in terms of resource planning, prioritization and
distribution. Therefore, the aim of this study was to assess TB
treatment outcome and associated factors among TB patients in
Wolayta Sodo Teaching and Referral Hospital, Southern Ethiopia.
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Significance for public health
In Ethiopia, recognition and amendment of treatment outcome is not feasible with poor surveillance system as well as limited monitoring and evaluation of
the health system. Accurate recording and reporting of TB treatment outcomes and associated factors is fundamental to facilitate the End TB Strategy set target
TB treatment success rate 90% by 2025. Identifying and measure this information is important for health professionals, programmers and policymakers in
terms of resource planning, prioritization and distribution.
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Design and Methods
Study design, study site and data collection
This facility based retrospective cohort study design was con-
ducted in Wolayta Sodo Teaching and Referral Hospital. The hos-
pital is the first teaching and referral hospital in Wolayta Sodo
Zonal Health Department which serves the community in the Zone
and referrals from different heath institutions. Data were extracted
from TB registry for all patients and analysis was done for out-
come status was documented. The date of treatment initiation was
the entry to cohort. Cohort exit was defined as treatment comple-
tion, death prior to treatment completion, treatment failure and loss
to follow-up. Data on independent variables and treatment out-
come were collected from TB clinic-based records. Information
available from the records included: place residence, age, sex,
mode of diagnosis, date of treatment onset, disease site, HIV status
and HIV treatment onset, treatment regimen, history of previous
TB treatment and treatment outcomes. Data were collected by
experienced staffs working in TB treatment unit. Data collectors
were trained and collected under the strict supervision by the prin-
cipal investigators.
Study population
A total of 2155 diagnosed as having all forms of TB were reg-
istered during September, 2014 to August, 2019. Of this, only 232
(11%) with known outcome were included in the study. TB
patients with incomplete data were excluded from the study.
Data collection and diagnosis
The data were collected using pretested structured data extrac-
tion questionnaire that included demographics (age, sex), clinical
history, laboratory, HIV test results, HIV treatment status, type and
category of TB and treatment outcomes. Diagnosis of TB was
made according to the recommendations of the Ministry of Health
(MoH) of Ethiopia.6 Treatment was based on the guidelines of the
country with a full course of anti-TB therapy (DOTs). Treatment of
new TB patients consists of a 2-month intensive phase with
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol followed by
a 4-month continuation phase with Rifampicin and Isoniazid.
Outcomes were categorized as successful (cured/completed) and
unsuccessful (loss to follow-up, failure and died).
Operational definition
Definitions of TB treatment outcome and case based on World
health organization (WHO) tuberculosis treatment guidelines
fourth edition.7
Cure: A patient whose sputum smear or culture was positive at
the beginning of the treatment but who was smear-or culture-neg-
ative in the last month of treatment and on at least one previous
occasion.
Treatment completed: A patient who completed treatment but
who does not have a negative sputum smear or culture result in the
last month of treatment and on at least one previous occasion
Treatment success: A sum of cured and completed treatment
complete
Treatment failure: A patient whose sputum smear or culture is
positive at 5 months or later during treatment. Also included in this
definition are patients found to harbor a multidrug resistant (MDR)
strain at any point of time during the treatment, whether they are
smear-negative or -positive.
Died: A patient who dies for any reason during the course of
treatment.
Default: A patient whose treatment was interrupted for 2 con-
secutive months or more.
Transfer out: A patient who has been transferred to another
recording and reporting unit and whose treatment outcome is
unknown.
New: Patients have never had treatment for TB, or have taken
anti-TB drugs for less than 1 month. 
Previously treated: Patients have received 1 month or more of
anti-TB drugs in the past, may have positive or negative bacteriol-
ogy and may have disease at any anatomical site.
Data management and analysis
Data were entered, cleaned, and analyzed using SPSS Version
23 for windows. Appropriate descriptive statistics such as mean
(with SD), median [with inter quartile range (IQR)], and frequen-
cies (with percentages) were used to describe the study population
in relation to relevant variables. Bivariate and multivariate analysis
with 95% confidence interval (CI) was employed to infer associa-
tions between the independent and dependent variables.
Binary and multivariable logistic regression analyses were
conducted to assess the effect of the different variables on the out-
come variable. All the explanatory variables with a p-value ≤0.2 in
the bivariate analyses were included in the final multivariable
logistic model in order to identify the independent predictors of TB
treatment outcome. A p-value<0.05 was considered statistically
significant. Crude odds ratio (COR) and Adjusted (AOR) with 95
% CI were calculated. Those associations with p-value less than
0.05 were regarded as statistically significant.
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Table 1. Socio-demographic and clinical characteristics of TB
patients attending Wolayta Sodo Referral Hospital, Southern
Ethiopia, 2019 (n=232).
Variables 
                                                           Frequency                   %
Sex                                            Female                       106                               45.7
                                                   Male                           126                               54.3
Age group (years)                   14                                52                                22.4
                                                   15-24                            63                                27.2
                                                   25-34                            64                                27.6
                                                   35-44                            29                                12.5
                                                   45-54                            18                                 7.8
                                                   55-64                             4                                  1.7
                                                    65                                 2                                  0.9
Residence                               Urban                         186                               80.2
                                                   Rural                           46                                19.8
Types of TB                              EPTB                           79                                33.6
                                                   SNPTB                         78                                34.5
                                                   SPPTB                         75                                31.5
Category of patients              New case                  225                               97.0
                                                   Re-treatment             7                                  3.0
Treatment regime                  First line                   232                              100.0
                                                   Second line                0                                  0.0
HIV status                                Negative                    192                               82.8
                                                   Positive                       40                                17.2
HIV treatment                         Started                        40                                100












The TB patient registration book between September 2014 and
August 2019 at Wolayita Sodo teaching and referral hospital was
reviewed. A total of 232 TB patients included in the study cohort
had documented treatment outcomes. More than half of these TB
patients 54.3% were male. The age of the study participants ranged
from 1 to 84 years, with a median of 25 years (IQR: 16.25-32
years). About 27.2% and 27.6% of the participants was in the age
range of 15-24 and 25-34, respectively. Of the 232 TB cases,
80.2% were urban residents (Table 1).
Clinical characteristics of patients
A total of 65.9% of the cases were pulmonary TB (PTB) and
of these 31.5% were smear positive PTB. A total of 40 (17.2%)
study participants were co-infected with HIV and all of them were
on antiretroviral treatment. Most, 97.0% of the TB cases, were
newly diagnosed. All of the participants treated as first line treat-
ment category (Table 1).
Treatment outcome of TB patients
Of the total TB patients with known treatment outcome, the
overall treatment success rate was 82.5%. Of these 65 (28%) were
cured and 126 (54.3%) had completed their treatment. The treat-
ment success rate of HIV-co-infected TB patients (n=40) included
in TB treatment outcome analysis was 77.5%. From a total of 39
(17.5%) unsuccessful TB treatment outcome cases, 26 (11.2%)
were loss to follow-up, 11 (4.7%) dead and 2 (0.9%) had treatment
failure (Figure 1). Higher treatment success rates were seen in
patients who were in the age group 15-24 year, female, Extra PTB
patients and HIV negative with 83.6% compared to 77.5% of the
HIV positives. The treatment cure was high among participants
with age group from 45-54, HIV negative, diagnosed as smear-
positive PTB and urban residence. The treatment completion was
also higher in the youngest age group (<14 and 15-24), participants
diagnosed as Extra PTB and rural residence. The rate of loss to fol-
low-up was low in patients who were male, urban residence, diag-
nosed with EPTB and HIV positive. Mortality was higher among
patients who were male, rural residency, HIV positive and patients
diagnosed as smear-negative PTB (Table 2).
Factors associated with treatment outcome of tubercu-
losis
Identifying the factor that contributes for the treatment out-
come of tuberculosis is very important to develop and recommend
prompt solutions. Accordingly, regression analysis was conducted
to assess whether treatment outcomes were associated with
patients’ sex, age, type of TB, HIV status and residence. Then, the
final model multivariate regression analysis was conducted to
assess independent relationship for all variables and none of them
had association with treatment outcomes of participants. Patients
with age group less than 14 and 15-24 years were more likely to
have poor treatment outcomes compared to TB patients with age
group greater than 25 years old [AOR: 0.431; 95% CI: (0.186-
1.000)] and (AOR:0.465 95% CI: 0.205-1.054), respectively. Male
patients were less likely to develop successful treatment outcome
as compared to the females with (AOR: 0.778 95% CI: 0.410-
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Table 2. Distribution of treatment outcome with socio-demographic and clinical characteristics of TB patients attending Wolayta Sodo
Referral Hospital, Southern Ethiopia, 2019 (n=232).
Variables                                Treatment cure   Treatment complete       Loss to follow-up      Treatment failure     Death of participants
Age                                       14                     6(11.5%)                         38(73.1%)                                 9(17.3%)                              0(0.0%)                                  0(0.0%)
                                             15-24               20(31.7%)                        34(54.0%)                                  6(9.5%)                                1(1.6%)                                   2(3.2%)
                                             25-34               22(34.4%)                        30(47.6%)                                 7(10.9%)                               1(1.6%)                                   2(3.1%)
                                             35-44                9(31.0%)                         12(41.4%)                                 3(10.3%)                               0(0.0%)                                  4(13.8%)
                                             45-54                7(38.9%)                          8(44.4%)                                   1(5.6%)                                0(0.0%)                                  2(11.1%)
                                              55                     1(16.7%)                         4(66.70%)                                  0(0.0%)                                0(0.0%)                                  1(16.7%)
Sex                                      Male                35(27.8%)                        67(53.6%)                                13(10.3%)                               1(.8%)                                    7(5.6%)
                                             Female           30(28.3%)                        59(55.7%)                                13(12.3%)                               1(.9%)                                    4(3.8%)
Type of TB                          SPPTB             59(78.8%)                          3(4.1%)                                   9(12.0%)                               1(1.3%)                                   3(4.0%)
                                             SNPTB              3(3.8%)                          59(75.6%)                                10(12.8%)                              1(1.3%)                                   5(6.4%)
                                             EPTB                 3(3.8%)                          64(81.0%)                                  7(8.9%)                                0(0.0%)                                   3(3.8%)
Residence                          Urban              55(29.6%)                        98(53.0%)                                20(10.8%)                              2(1.1%)                                   8(4.3%)
                                             Rural               10(21.7%)                        28(60.9%)                                 6(13.0%)                               0(0.0%)                                   3(6.5%)
HIV status                          Positive          10(25.0%)                        21(52.5%)                                 4(10.0%)                               1(2.5%)                                   3(7.5%)
                                             Negative         55(28.6%)                       105(55.0%)                               22(11.5%)                               1(.5%)                                    8(4.2%)
Total                                    65(28.0%)     126(54.5%)                       26(11.2%)                                  2(0.9%)                               11(4.7%)
TB, tuberculosis; HIV, human immune deficiency virus.
Figure 1. Distribution of treatment outcome among TB patients











1.477). Patients with smear negative (PTB-ve) were more likely to
have successful treatment outcome as compared to patients with
EPTB and smear positive pulmonary TB (AOR = 1.249, 95% CI;
0.530-2.946) (Table 3).
Discussion
In our study, the burden of TB was higher among the age
groups of 14-24 and 25-34 years with 27.2% and 27.6% respec-
tively. This is in line with many similar studies,8-10 which confirm
as TB mainly affects sexually active and reproductive age groups.
The proportion of patients’ category were 153 (65.9%) pul-
monary TB, whom 78 (33.6%) were smear negative PTB and 79
(34.1%) extra pulmonary TB. The proportion of smear positive
PTB is 31.5% which was in line of study reported from Harar
town (32.4%)11 and higher than the reports from deferent parts of
Ethiopia, East Wollega 20.3,1 Alamata District 23.5%,10 Debre
Tabor 24.5%,9 Debre Tabor 26.7.12 According to the WHO defini-
tion smear-positive pulmonary TB cases should have at least one
acid fast bacillus (AFB+) in at least one sputum sample in coun-
tries with a well-functioning EQA system.7 Patients who came to
the health facility with TB sign and symptom and had negative
result for AFB microscope for any reason will be clinically diag-
nosed as smear negative PTB. This may contribute for the low rate
of Smear positive PTB cases. On the top of this most of the health
facilities in Ethiopia have been using AFB microscopy due to lim-
ited resources, which has low sensitivity (40-45%) and might con-
tribute to lower notification rates of PTB+ (observation).9
The overall proportion of successful treatment outcome among
the TB patients included in this study was 191 (82.5%) with
65(28%) were cured and 126 (54.5%) had completed. The finding
of our study shows nearly similar treatment outcome compared to
a finding of systematic review and meta-analysis conducted in
Ethiopia which describes that the overall TB treatment success rate
was 86% with subgroup analysis of Addis Ababa (93%), Oromia
(84%), Amhara (86%), SNNPR (83%), Tigray (85%) and Afar
(86%).13 Again the finding of the present study was comparable
with a systematic review reporting the pooled estimate TB treat-
ment outcome of 83.7%, and sub-group analysis findings of Afar
88.9%, Oromia 88.5% and Gambella 86.1%.4 This is by consider-
ing the fact that the systematic review and meta- analysis were
reporting aggregate findings of articles conducted in different time
period in which the findings of studies conducted previously may
affect the overall pooled results. The proportion of patients with
successful treatment outcomes was found to be nearly similar with
global and Ethiopian treatment success rate of 83% and 84%,
respectively.7
However the finding of the present study showed low over all
treatment outcome compared to many reports from different parts
of Ethiopia, Harar Town 92.5%,11 Alamata 90.1%,10 Ethiopia
90.9%,14 Debre Tabor 90.1%,9 East Wollega 91.9%,1 Southwest
Ethiopia 89.7%,15 Southern Ethiopia 89.9%.8 This low treatment
success rate compared to the recent studies might be due to poor
implementation of DOTs strategy, counseling service and poor
health care utilization behavior of the community which was indi-
cated by high loss to follow up 11.2% compared to reports from
Harar Town 2.4%,11 Hosanna 1.4%,16 Eastern Ethiopia 1.8%,17
East Wollega 2.9%,1 Northern Ethiopia 2.5%.18 Excluding all
transfer out patients in the study may also another reason to have
large proportion of unsuccessful treatment outcome since most
transfer out patients expected to have better progress than patients
need to follow in the hospital in the intensive treatment phase. The
findings of the current study had slightly higher treatment success
rate compared to reports from Eastern Ethiopia 78.3%,17 Northern
Ethiopia 79.5%18 and Jinka 74%,19 Busan, South Korea 83.9%.20
The logistic regression analysis of our study shows TB treatment
outcome was not significantly associated with patients’ age, sex,
type of TB and residence of participants (Table 3). Where us stud-
ies conducted in different parts of Ethiopia were report an associa-
tion between TB treatment outcome with age,11,12,13,20,21
sex,1,11,12,20 type of TB,16,21 HIV status,1,11,13,16 and resi-
dence1,11,12,16,22 the participants. The difference may be due to the
size of the study participants and the statistical pooling effect of the
reference groups. The prevalence of HIV among the patients in this
study was 40 (17%), which is comparable with the reports from
Hosanna 16.3%16 and Oromia region 18.6%.23 However the find-
ing of the present study shows low HIV positive prevalence in con-
trast to the findings from Amhara region 24.2%,24 Harar Town
22.8%,11 and Debre Tabor 24.2%.9 The finding also shows higher
rate of HIV positive status compared to the range of findings from
6.8% to 13.5%.1,10,11 This variability may be due to differences in
the health care service in different parts of the country, the health
care utilization behavior of the community and access to the health
care facility. Again, it may be because of the difference of HIV
prevalence in regions. Although our study has a significant input
for researchers and policy makers, it was not possible to determine
all factors which could affect treatment outcomes since the results
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Table 3. Multivariate analysis of treatment outcome with socio-demographic and clinical characteristics of TB patients attending
Wolayta Sodo Refereal Hospital, Southern Ethiopia, 2019 (n=232).
                                  Tuberculosis treatment outcome                  
Characteristics                                         Successful            Unsuccessful            Crude OR                   p              Adjusted OR             p
                                                                   treatment               treatment              (95% CI)                                   (95% CI)
Age                                         14                                     44(84.6%)                         8(15.4%)               0.735(0.305-1.774)               0.494           0.431(0.186-1.000)            0.05
                                               15-24                                54(85.7%)                         9(14.3%)               0.674(0.291-1.562)               0.357            0.465(0.205-1.054            0.067
                                                25                                    93(80.2%)                        23(19.8%)                              1                                                                   1                               
Sex                                        Male                                102(81.6%)                       23(18.4%)              1.181(0.593-2.350)               0.637           0.778(0.410-1.477)           0.442
                                               Female                              89(84%)                           17(16%)                               1                                                                   1                               
Type of TB                            PPTB                                60(83.7%)                        12(16.7%)              1.100(0.459-2.634)               0.831            1.013(0414-2.477)            0.978
                                               NPTB                                 64(80%)                           16(20%)                1.375(0.603-3.133)               0.449           1.249(0.530-2.946)           0.611
                                               EXPT                                66(84.6%)                        12(15.4%)                              1                                                                   1                               
HIV status                           Positive                           31(77.5%)                         9(22.5%)               1.498(0.650-3.457)               0.343           0.959(0.411-2.236)           0.923
                                               negative                          160(83.8%)                       31(16.2%)                              1                                                                  1                               
Residence                           Urban                              153(82.7%)                       32(17.3%)              0.993(0.424-2.330)               0.988           1.013(0.426-2.410)           0.977
                                               Rural                                38(82.6%)                         8(17.4%)                               1                                                                  1                               
TB, tuberculosis; PPTB, pediatric pulmonary tuberculosis; NPTB, nasopharyngeal tuberculosis; EXPT, smear positive pulmonary TB; HIV, human immune deficiency virus.









were based on secondary data which routinely collected from
health facilities. It was not able to assess factors of TB treatment
outcome that are related to the patients, the health care providers
and the health service. Moreover, since the study was conducted in
a single hospital it was difficult to generalize the findings to all TB
patients.
Conclusions and Recommendation
The treatment success rate of tuberculosis patients treated at
Wolayta Sodo Teaching and Referral Hospital was disproportion-
ally low (82.5%) below the 85% threshold defined standards. A
high proportion of patient’s lost to follow-up (11.2%) which is a
serious public health concern that needs to be addressed urgently.
A higher number of transfer-out cases were recorded in this
study. Thus, the studied health facility should network with other
health service centers to document the treatment outcomes of
patients. Thus, enhanced supervision and monitoring of DOTs
strategy implementation, improved counseling service, community
identification of lost to follow-up patients and establish efficient
referral and contact tracing mechanisms for transferred-out cases.
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